Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Pain Science Education for Children Living With and Beyond Cancer: Challenges and Research Agenda
  • +2
  • Emma Rheel,
  • Lauren Heathcote,
  • Jutte Van der Werff-ten Bosch,
  • Fiona Schulte,
  • Joshua Pate
Emma Rheel
Vrije Universiteit Brussel

Corresponding Author:[email protected]

Author Profile
Lauren Heathcote
King's College London Institute of Psychiatry Psychology and Neuroscience
Author Profile
Jutte Van der Werff-ten Bosch
University Hospital Brussels
Author Profile
Fiona Schulte
University of Calgary Cumming School of Medicine
Author Profile
Joshua Pate
University of Technology Sydney
Author Profile

Abstract

Pain in children living with and beyond cancer is understudied and undertreated. Pain science education (PSE) is a conceptual change strategy facilitating patients’ understanding of the biopsychosocial aspects of pain. Preliminary studies on the adaptation of PSE interventions to adults with and beyond cancer provide a foundation for pediatric research. PSE could help childhood cancer survivors experiencing persistent pain and pain-related worry after active treatment. PSE may also help children receiving cancer treatment, providing them with a foundation of adaptive pain beliefs and cognitions, and preparing them for procedural and treatment-related pain. We direct this paper towards pediatric oncology clinicians, policy makers and researchers working with children living with and beyond cancer. We aim to; (1) identify challenges in adapting PSE for children living with and beyond cancer, (2) offer possible solutions, and (3) propose research questions to guide the implementation of PSE for children living with and beyond cancer.
27 Jan 2022Submission Checks Completed
27 Jan 2022Assigned to Editor
27 Jan 2022Submitted to Pediatric Blood & Cancer
02 Feb 2022Reviewer(s) Assigned
15 Feb 2022Review(s) Completed, Editorial Evaluation Pending
05 Mar 2022Editorial Decision: Revise Major
05 Apr 2022Submission Checks Completed
05 Apr 2022Assigned to Editor
05 Apr 20221st Revision Received
06 Apr 2022Reviewer(s) Assigned
20 Apr 2022Review(s) Completed, Editorial Evaluation Pending
20 Apr 2022Editorial Decision: Revise Minor
27 Apr 20222nd Revision Received
27 Apr 2022Submission Checks Completed
27 Apr 2022Assigned to Editor
28 Apr 2022Review(s) Completed, Editorial Evaluation Pending
29 Apr 2022Editorial Decision: Accept